Abstract
Four papers in Nature Medicine paint a picture of adipose tissue inflammation as the bridge between obesity and insulin resistance, a hallmark of type 2 diabetes.1, 2, 3, 4 The findings argue for treating the disease with mAbs for CD3, a target on T cells that is already being pursued in type 1 diabetes by Tolerx Inc., MacroGenics Inc. and others. ...
Cite
CITATION STYLE
APA
Osherovich, L. (2009). Dousing diabetes’ flames. Science-Business EXchange, 2(31), 1198–1198. https://doi.org/10.1038/scibx.2009.1198
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free